PALO ALTO, Calif. and
HEFEI, China, April 8, 2019 /PRNewswire/ -- Varian (NYSE: VAR)
today announced the installation of the cyclotron for the Varian
ProBeam® proton therapy system at Hefei Ion
Medical Center (HIMC) in China.
The cyclotron is a core piece of equipment in the ProBeam proton
therapy system, and its installation marks a key milestone for
every new proton therapy center. When completed, HIMC will
feature three proton therapy treatment rooms with full 360-degree
rotational gantries as well as a fixed-beam treatment room and a
research room.
Varian's ProBeam system is the first to offer fully-integrated
intensity modulated proton therapy (IMPT) to enable more efficient
adaptive proton therapy. Varian's pencil-beam scanning technology
gives clinicians the ability to deliver the dose precisely within
the contours of the tumor to minimize dose to healthy tissue. When
combined with high quality cone-beam computed tomography (CBCT),
the ProBeam system enables sophisticated image guidance during
the course of treatment, helping to make it a more precise form of
proton therapy. In combination with the ARIA® oncology
information system and Eclipse™ treatment planning system, the
ProBeam system enables an efficient adaptive workflow.
"We are excited to have achieved this important milestone by
successfully installing the cyclotron for the first ProBeam proton
therapy system in China," said
Kolleen Kennedy, president, Proton
Solutions and chief growth officer, Varian. "We look forward to our
continuing partnership with HIMC to complete the construction of
this flagship proton center and expand access to this cutting edge
cancer treatment in China."
"In mainland China there were
3.9 million new cancer cases reported in 2015*, over 10 thousand
people are diagnosed with cancer every day, but only one authorized
medical center providing particle therapy treatment," said
Li Bing, director of HMIC. "As one
of the significant technological innovation programs for Hefei
Comprehensive National Science Center, HIMC is proud to have
achieved this new important milestone of the cyclotron
installation, because it moves us closer to completing the center
and achieving our goal of providing this advanced cancer treatment
to 2000 patients a year."
*Report of Cancer Epidemiology in China, 2015, China Journal Oncology,
January 2019
About Varian
Varian is a leader in developing and
delivering cancer care solutions and is focused on creating a world
without fear of cancer. Headquartered in Palo Alto, California, Varian employs
approximately 7,000 people around the world. For more
information, visit http://www.varian.com and follow @VarianMedSys
on Twitter.
Press Contact
Mark Plungy
Director, Global Public Relations
+1 (650) 424-5630
mark.plungy@varian.com
Helen Yang
Manager, Greater China Public Relations
+86 (10) 87836354
helen.yang@varian.com
Investor Relations Contact
J. Michael Bruff
Senior Vice President, Investor Relations
+1 (650) 424-5163
investors@varian.com
View original
content:http://www.prnewswire.com/news-releases/varian-installs-cyclotron-for-probeam-proton-therapy-system-at-hefei-ion-medical-center-in-china-300825703.html
SOURCE Varian